Zevra Therapeutics, Inc. logo ZVRA - Zevra Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 8
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $25.50 DETAILS
HIGH: $26.00
LOW: $25.00
MEDIAN: $25.50
CONSENSUS: $25.50
UPSIDE: 154.24%

Profitability Ratios

Ratio Value
GP Margin 84.5%
EBIT Margin 88.9%
EBITDA Margin 92.7%
Operating Margin -4.0%
Pretax Margin 81.4%
Cont. Ops Margin 78.2%
Net Margin 78.2%
Bottom Line Margin 72.9%

Liquidity Ratios

Ratio Value
Current Ratio 5.68
Quick Ratio 5.63
Solvency Ratio 0.671
Cash Ratio 1.59

Valuation Ratios

Ratio Value
Price/Earnings
5.95
Hist. avg: 6.0
Peers avg: 13.2
PEG Ratio -0.04
Forward PEG -0.04
Price/Book 3.20
Price/Sales 4.65
Price/FCF -203.69
Price/Op Cash Flow -310.13

Debt Ratios

Ratio Value
Debt/Assets 0.2220
Debt/Equity 0.4087
Debt/Capital 0.2901
Long-Term Debt/Capital 0.2859
Financial Leverage 1.84

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.90
Operating Cash Flow Ratio -0.041
Operating Cash Flow/Sales -1.5%
Free Cash Flow/Operating Cash Flow 152.3%

Coverage Ratios

Ratio Value
Debt Service Coverage 11.94
Interest Coverage -0.5307
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage -0.03
Capital Expenditure Coverage -1.91
Dividend + Capital Expenditure Coverage -1.91

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 1.92
EPS 1.505
Debt/Share 1.2870
Cash/Share 3.45
Book Value/Share 2.80
Tangible BV/Share 2.60
Equity/Share 2.80
Operating Cash Flow/Share -0.029
Capital Expenditure/Share 0.015
FCF/Share -0.044

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.960
Earnings Before Tax/EBIT -20.477
Price/Fair Value 3.20
Debt/Market Cap 0.1250
Effective Tax Rate 4.0%
Enterprise Value Multiple 5.03